Related Experiment Video

Updated: May 7, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Non-Darwinian dynamics in therapy-induced cancer drug resistance

Angela Oliveira Pisco1,2, Amy Brock3, Joseph Zhou1,4

  • 1Institute for Systems Biology, Seattle WA 98109, USA.

Nature Communications
|September 19, 2013
PubMed

Insights

Drug resistance in leukemia isn't solely due to genetic mutations. Instead, Lamarckian induction, a non-genetic process, drives multidrug resistance, offering new therapeutic targets.

Area of Science:

  • Cancer Biology
  • Cellular Heterogeneity
  • Drug Resistance Mechanisms

Background:

  • Drug resistance is a major cause of cancer therapy failure, often attributed to genetic mutations.
  • Non-genetic cellular heterogeneity generates transient resistant states (persisters) that can be selected without mutations.
  • Understanding resistance mechanisms is crucial for improving cancer treatment efficacy.

Purpose of the Study:

  • To investigate the mechanism of multidrug resistance development in HL60 leukemic cells after vincristine treatment.
  • To differentiate between Darwinian selection and Lamarckian induction as drivers of resistance.
  • To identify potential therapeutic targets for preventing drug resistance.

Main Methods:

  • Quantitative measurements and mathematical modeling of HL60 leukemic cell populations.
  • Single-cell longitudinal monitoring to track resistance development in individual cells.
  • Transcriptome analysis to identify associated molecular changes and pathways.

Main Results:

  • Multidrug resistance in HL60 cells treated with vincristine is induced, not selected by Darwinian evolution.
  • Single-cell studies confirmed the induction of resistance in individual cells.
  • Transcriptome changes indicated a lasting stress response and Wnt pathway upregulation, which was suppressed by beta-catenin knockdown.

Conclusions:

  • The emergence of multidrug resistance in this model is driven by Lamarckian induction, a non-genetic mechanism.
  • Wnt pathway activation is implicated in resistance induction, presenting a potential therapeutic target.
  • Targeting the Wnt pathway may offer a strategy for early intervention against drug resistance development.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...